healthcare
Analysis-Hims' $49 weight-loss pill rattles investor case for cash-pay obesity market
Novo Nordisk shares rebound as FDA targets illegal drug copies
Danone recalls more baby formula in Europe after EU sets toxin threshold
Novo Nordisk CEO says Hims $49 compounded Wegovy pill a 'waste' of money
Novo Nordisk to take legal action against Hims & Hers for Wegovy compounding
Date: February 5, 2026
COPENHAGEN, Feb 5 (Reuters) - Novo Nordisk said on Thursday it would take legal action against Hims & Hers after the online telehealth company said it will begin offering compounded copies of the...
Hims offers cheapest GLP-1 weight-loss pill in US in a shock to Novo, Lilly
Date: February 5, 2026
NEW YORK, Feb 5 (Reuters) - Online telehealth company Hims and Hers Health will begin offering copies of Novo Nordisk's new Wegovy pill at an introductory price of $49 per month, the company said...
Analysis-Novo Nordisk risks weight-loss price war as discount pressures deepen
Date: February 4, 2026
By Maggie Fick, Jacob Gronholt-Pedersen and Bhanvi Satija LONDON, Feb 4 (Reuters) - Danish obesity drug maker Novo Nordisk's new CEO risks being on the losing side of a damaging price war as "...
European stocks close at record high even as tech, healthcare drag
Date: February 4, 2026
Feb 4 (Reuters) - European shares were muted on Wednesday as losses in Novo Nordisk offset strength in energy stocks, with investors also tracking software shares and awaiting a key inflation report....
Novo Nordisk sees 'painful' US price cuts for Wegovy as investment in the future
Date: February 4, 2026
COPENHAGEN, Feb 4 (Reuters) - Novo Nordisk CEO Mike Doustdar said on Wednesday that the price reductions for its obesity drug Wegovy in the U.S. are "painful" for the company's financial results but...

Spain performs pioneering face transplant from donor who requested assisted dying
Date: February 2, 2026
MADRID, Feb 2 (Reuters) - A hospital in Barcelona said on Monday it had performed a pioneering facial transplant in which the donor, in a world first, had offered her face for donation before...
